These 4 imaging biomarkers enabled development of a signature, which offered high specificity and sensitivity, to steer the clinical decision to keep EGFR targeted therapies. …
Cytochrome P450
Hung WY, Wu CW, Yin PH, Chang CJ, Li AF, Chi CW, Wei YH, Lee HC
Hung WY, Wu CW, Yin PH, Chang CJ, Li AF, Chi CW, Wei YH, Lee HC. in response to mitochondrial dysfunction-increased reactive air species (ROS) …